Association of Metabolic dysfunction‐associated steatotic liver disease, MASLD, with Cognitive Function in a Brazilian Cohort

AAIC 2025 Abstract

Abstract

Background: Metabolic dysfunction‐associated steatotic liver disease (MASLD) has recently been studied as a potential risk factor for cognitive decline (CD). However, the evidence in the literature shows conflicting results.

The paper

Universidade Federal do Rio Grande do Sul

AAIC 2025 Abstract · 23 Dec 2025 · CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70860_101804